Oral Delivery Platform
[TABS_R id=1827] Go to Specific Tab
The Oral Delivery Platform consists of biodegradable microparticles (many times smaller than a single grain of sand) that incorporate an optimized mixture of cancer-specific immunotargets, immuno-stimulatory compounds, and lymphatic system targeting moieties that are designed to effectively and safely engage a powerful immunogenic response against cancer cells throughout the body. Passing through the small intestine, these microparticles deliver their potent immune stimulating cargo to regional antigen presenting cells, which then orchestrate a robust and specific activation of cytotoxic T-cells, resulting in an efficient and potentially durable anticancer response. The system has the capacity to deliver a strong, safe, and efficient off-the-shelf product due to a straightforward and flexible manufacturing process that is designed to deliver a cost-effective and cancer-tailored product.